1. Home
  2. PRSO vs CHRO Comparison

PRSO vs CHRO Comparison

Compare PRSO & CHRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRSO
  • CHRO
  • Stock Information
  • Founded
  • PRSO 2008
  • CHRO 2002
  • Country
  • PRSO United States
  • CHRO United States
  • Employees
  • PRSO N/A
  • CHRO N/A
  • Industry
  • PRSO Semiconductors
  • CHRO
  • Sector
  • PRSO Technology
  • CHRO
  • Exchange
  • PRSO Nasdaq
  • CHRO Nasdaq
  • Market Cap
  • PRSO 4.2M
  • CHRO 4.2M
  • IPO Year
  • PRSO 2001
  • CHRO 2024
  • Fundamental
  • Price
  • PRSO $1.04
  • CHRO $0.60
  • Analyst Decision
  • PRSO Strong Buy
  • CHRO Strong Buy
  • Analyst Count
  • PRSO 2
  • CHRO 1
  • Target Price
  • PRSO $3.38
  • CHRO N/A
  • AVG Volume (30 Days)
  • PRSO 125.2K
  • CHRO 121.3K
  • Earning Date
  • PRSO 11-12-2024
  • CHRO 11-13-2024
  • Dividend Yield
  • PRSO N/A
  • CHRO N/A
  • EPS Growth
  • PRSO N/A
  • CHRO N/A
  • EPS
  • PRSO N/A
  • CHRO N/A
  • Revenue
  • PRSO $12,728,000.00
  • CHRO N/A
  • Revenue This Year
  • PRSO $9.59
  • CHRO N/A
  • Revenue Next Year
  • PRSO $1.63
  • CHRO N/A
  • P/E Ratio
  • PRSO N/A
  • CHRO N/A
  • Revenue Growth
  • PRSO N/A
  • CHRO N/A
  • 52 Week Low
  • PRSO $0.73
  • CHRO $0.45
  • 52 Week High
  • PRSO $11.20
  • CHRO $6.00
  • Technical
  • Relative Strength Index (RSI)
  • PRSO 55.90
  • CHRO 48.49
  • Support Level
  • PRSO $0.80
  • CHRO $0.55
  • Resistance Level
  • PRSO $1.12
  • CHRO $0.71
  • Average True Range (ATR)
  • PRSO 0.09
  • CHRO 0.10
  • MACD
  • PRSO 0.05
  • CHRO -0.00
  • Stochastic Oscillator
  • PRSO 88.69
  • CHRO 23.98

About PRSO Peraso Inc.

Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz, to 300 GHz. Geographically the company generates revenue from the United States, Hong Kong, Taiwan, and the Rest of the World.

About CHRO Chromocell Therapeutics Corporation

Channel Therapeutics Corp is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain. The initial clinical focus is to selectively target the sodium ion channel known as NaV1.7 for the treatment of various types of chronic pain, acute and chronic eye pain, and post-surgical nerve blocks. Its pipeline includes CC8464 for ISFN and EM and CT2000 for Acute and CHronic Eye Pain-Dry Eye Disease.

Share on Social Networks: